Style | Citing Format |
---|---|
MLA | Esmailzadeh A, et al.. "Sonodynamic Therapy Using Dacarbazine-Loaded Ausio2 Nanoparticles for Melanoma Treatment: An In-Vitro Study on the B16f10 Murine Melanoma Cell Line." Ultrasound in Medicine and Biology, vol. 48, no. 6, 2022, pp. 1131-1142. |
APA | Esmailzadeh A, Shanei A, Attaran N, Hejazi SH, Hemati S (2022). Sonodynamic Therapy Using Dacarbazine-Loaded Ausio2 Nanoparticles for Melanoma Treatment: An In-Vitro Study on the B16f10 Murine Melanoma Cell Line. Ultrasound in Medicine and Biology, 48(6), 1131-1142. |
Chicago | Esmailzadeh A, Shanei A, Attaran N, Hejazi SH, Hemati S. "Sonodynamic Therapy Using Dacarbazine-Loaded Ausio2 Nanoparticles for Melanoma Treatment: An In-Vitro Study on the B16f10 Murine Melanoma Cell Line." Ultrasound in Medicine and Biology 48, no. 6 (2022): 1131-1142. |
Harvard | Esmailzadeh A et al. (2022) 'Sonodynamic Therapy Using Dacarbazine-Loaded Ausio2 Nanoparticles for Melanoma Treatment: An In-Vitro Study on the B16f10 Murine Melanoma Cell Line', Ultrasound in Medicine and Biology, 48(6), pp. 1131-1142. |
Vancouver | Esmailzadeh A, Shanei A, Attaran N, Hejazi SH, Hemati S. Sonodynamic Therapy Using Dacarbazine-Loaded Ausio2 Nanoparticles for Melanoma Treatment: An In-Vitro Study on the B16f10 Murine Melanoma Cell Line. Ultrasound in Medicine and Biology. 2022;48(6):1131-1142. |
BibTex | @article{ author = {Esmailzadeh A and Shanei A and Attaran N and Hejazi SH and Hemati S}, title = {Sonodynamic Therapy Using Dacarbazine-Loaded Ausio2 Nanoparticles for Melanoma Treatment: An In-Vitro Study on the B16f10 Murine Melanoma Cell Line}, journal = {Ultrasound in Medicine and Biology}, volume = {48}, number = {6}, pages = {1131-1142}, year = {2022} } |
RIS | TY - JOUR AU - Esmailzadeh A AU - Shanei A AU - Attaran N AU - Hejazi SH AU - Hemati S TI - Sonodynamic Therapy Using Dacarbazine-Loaded Ausio2 Nanoparticles for Melanoma Treatment: An In-Vitro Study on the B16f10 Murine Melanoma Cell Line JO - Ultrasound in Medicine and Biology VL - 48 IS - 6 SP - 1131 EP - 1142 PY - 2022 ER - |